COVID-19

The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing…

The company had earlier hoped to launch it only in the second quarter of next year.

The fresh investment will increase vial production by 300 million pieces within 12 months

The COVID-19 halo effect is driving extra funding to many small pharma companies, especially those in the infectious disease space

Researchers to develop and deploy serological (antibody) testing assays as well as study the molecular mechanisms driving…

The study finds that the nanoparticle vaccine generates ten times more protective antibodies in mice, even at a six-fold lower…

Bharat Serums and Vaccines has initiated a research project to co-develop an equine polyclonal antibody, along with NIV, against…

It can selectively modulate the inflammatory responses caused by the ‘Cytokine Storm’ in ARDS, COVID19 and other inflammatory…

Ask for details of specific indications for which approval has been granted, any conditions or restrictions attached to the…

The antibody slows down the replication process, allowing the patient's own immune system time to kick into gear